Final Answer:
Trumenba is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B.
Step-by-step explanation:
Trumenba is a vaccine designed to protect against invasive disease caused by Neisseria meningitidis serogroup B. Neisseria meningitidis is a bacterium that can cause severe and potentially life-threatening infections, such as meningitis and septicemia. Serogroup B is one of the several serogroups of this bacterium. Trumenba is a meningococcal B vaccine that stimulates the immune system to produce an immune response against serogroup B. This vaccination is particularly important for individuals at increased risk of exposure to the bacteria, such as adolescents and young adults, as meningococcal infections can spread rapidly and lead to serious health complications.